Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry W Long

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Nature Cancer|April 10, 2023
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancerMartin K Bakht, Yasutaka Yamada, Sheng-Yu Ku, et al.
JCI Insight|May 23, 2022
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistromeXintao Qiu, Lisha G Brown, Jennifer L Conner, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerBeatriz German, Katherine L Morel, Teia Noel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2019
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)Ying Z Mazzu, Joshua Armenia, Goutam Chakraborty, et al.
Cancer Research|September 2, 2020
Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder CancerJoaquim Bellmunt, Jaegil Kim, Brendan Reardon, et al.
Nature Medicine|April 26, 2016
Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profilesPaloma Cejas, Lewyn Li, Nicholas K O'Neill, et al.
Nature Cell Biology|November 5, 2021
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistanceYihao Li, Xintao Qiu, Xiaoqing Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancerBetul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
Cancer Discovery|May 4, 2021
Inhibition of CDK4/6 Promotes CD8 T-cell Memory FormationMax Heckler, Lestat R Ali, Eleanor Clancy-Thompson, et al.
Nature Communications|July 2, 2025
Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancerKei Mizuno, Sheng-Yu Ku, Varadha Balaji Venkadakrishnan, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Nature Cancer|April 10, 2023
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancerMartin K Bakht, Yasutaka Yamada, Sheng-Yu Ku, et al.
JCI Insight|May 23, 2022
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistromeXintao Qiu, Lisha G Brown, Jennifer L Conner, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerBeatriz German, Katherine L Morel, Teia Noel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2019
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)Ying Z Mazzu, Joshua Armenia, Goutam Chakraborty, et al.
Cancer Research|September 2, 2020
Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder CancerJoaquim Bellmunt, Jaegil Kim, Brendan Reardon, et al.
Nature Medicine|April 26, 2016
Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profilesPaloma Cejas, Lewyn Li, Nicholas K O'Neill, et al.
Nature Cell Biology|November 5, 2021
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistanceYihao Li, Xintao Qiu, Xiaoqing Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancerBetul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
Cancer Discovery|May 4, 2021
Inhibition of CDK4/6 Promotes CD8 T-cell Memory FormationMax Heckler, Lestat R Ali, Eleanor Clancy-Thompson, et al.
Nature Communications|July 2, 2025
Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancerKei Mizuno, Sheng-Yu Ku, Varadha Balaji Venkadakrishnan, et al.
Pageof 10